Stericycle (SRCL)
(Delayed Data from NSDQ)
$46.94 USD
+0.03 (0.06%)
Updated May 10, 2024 04:00 PM ET
After-Market: $46.91 -0.03 (-0.06%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth D Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$46.94 USD
+0.03 (0.06%)
Updated May 10, 2024 04:00 PM ET
After-Market: $46.91 -0.03 (-0.06%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth D Momentum D VGM
Zacks News
Stericycle (SRCL) Stock Down 5.7% Despite Q3 Earnings Beat
by Zacks Equity Research
Stericycle's (SRCL) third-quarter 2020 earnings and revenues declined year over year.
Stericycle (SRCL) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Stericycle (SRCL) delivered earnings and revenue surprises of 19.30% and 0.01%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Stericycle (SRCL) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Stericycle (SRCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
QRHC or SRCL: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
QRHC vs. SRCL: Which Stock Is the Better Value Option?
QRHC vs. SRCL: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
QRHC vs. SRCL: Which Stock Is the Better Value Option?
Stericycle (SRCL) Down 1% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Stericycle (SRCL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Stericycle (SRCL) Stock Up 1.5% Since Q2 Earnings: Here's Why
by Zacks Equity Research
Stericycle's (SRCL) stock has been rising since it reported second-quarter 2020 results, which reflect better-than-expected top- and bottom-line performances.
Stericycle (SRCL) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Stericycle (SRCL) delivered earnings and revenue surprises of 84.00% and 3.34%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Stericycle (SRCL) Q2 Earnings Expected to Decline
by Zacks Equity Research
Stericycle (SRCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Focus on Waste Removal Stocks Resilient to Coronavirus Mayhem
by Shuvra Shankar Dey
Amid the coronavirus outbreak, people aren't expected to stop generating waste, and disposal of trash, thus, is a key concern.
Stericycle (SRCL) Up 24.8% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Stericycle (SRCL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Stericycle (SRCL) Grapples With Declining CRS Businesses
by Zacks Equity Research
Declining CRS businesses and risks associated with foreign currency exchange rate fluctuations have been weighing on Stericycle's (SRCL) top line.
Stericycle (SRCL) Q1 Earnings Miss Estimates, Down Y/Y
by Zacks Equity Research
Stericycle's (SRCL) first-quarter 2020 earnings and revenues decline year over year.
Stericycle (SRCL) Q1 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Stericycle (SRCL) delivered earnings and revenue surprises of -20.00% and -2.46%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Stericycle (SRCL) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Stericycle (SRCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Stericycle Completes Sale of Domestic Environmental Solutions
by Zacks Equity Research
The latest divestiture, being the sixth one in the past 15 months, reflects Stericycle's (SRCL) progress on its portfolio rationalization efforts.
Harsco Acquires Stericycle's Environmental Solutions Business
by Zacks Equity Research
Harsco's (HSC) buyout of Stericycle's Environmental Solutions business is likely to boost its environmental solutions and services business. The acquired assets will complement Harsco's Clean Earth business.
Stericycle (SRCL) Down 31.6% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Stericycle (SRCL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Stericycle (SRCL) Hits a New 52-Week Low: What's Ailing It?
by Zacks Equity Research
Consecutive lower-than-expected top-line performance, declining CRS businesses and foreign currency exchange rate fluctuations are weighing on Stericycle (SRCL) stock.
Stericycle (SRCL) Q4 Earnings Beat Estimates, Revenues Lag
by Zacks Equity Research
Stericycle (SRCL) fourth-quarter 2019 earnings and revenues decrease year over year.
Stericycle (SRCL) Beats Q4 Earnings Estimates
by Zacks Equity Research
Stericycle (SRCL) delivered earnings and revenue surprises of 2.86% and -0.37%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
What's in the Cards for Stericycle's (SRCL) Q4 Earnings?
by Zacks Equity Research
Stericycle's (SRCL) fourth-quarter 2019 earnings and revenues are likely to have declined year over year.
What's in the Cards for FTI Consulting's (FCN) Q4 Earnings?
by Zacks Equity Research
FTI Consulting's (FCN) fourth-quarter 2019 revenues are likely to have benefited from strength in all segments.
Avis Budget (CAR) Surpasses Q4 Earnings & Revenue Estimates
by Zacks Equity Research
Avis Budget (CAR) fourth-quarter 2019 earnings and revenues improve year over year.
TransUnion (TRU) Surpasses Q4 Earnings & Revenue Estimates
by Zacks Equity Research
TransUnion's (TRU) fourth-quarter 2019 earnings and revenues improve year over year.